Body Composition and Physical Activity in End-Stage Renal Disease
Objective
The study objective was to examine the relationship between visceral and somatic protein stores and physical activity in individuals with end-stage renal disease.
Design
This was a prospective single-center study.
Setting
The study took place at the Vanderbilt University Outpatient Dialysis Unit and General Clinical Research Center.
Patients
Fifty-five patients with prevalent chronic hemodialysis (CHD) were included: 33 males, 22 females, 45 African Americans, 9 Caucasians, and 1 Asian. The mean age was 47.0 ± 1.6 years, height was 166.4 ± 13.9 cm, and weight was 83.1 ± 2.6 kg.
Methods
Body composition was measured by dual-energy x-ray absorptiometry. Minute-by-minute physical activity was assessed over a 7-day period with a triaxial accelerometer. Participants were interviewed by a trained registered dietitian for two 24-hour diet recalls (one from a hemodialysis day; one from a nonhemodialysis day). Laboratory values for serum concentrations of albumin, prealbumin, C-reactive protein, and creatinine were also collected.
Main Outcome Measure
Predictors of somatic protein stores were the main outcome measure.
Results
Serum albumin was negatively and significantly correlated with the percentage of fat mass (P = .016) and kg of fat mass (P = .044). C-reactive protein was positively and significantly correlated with body weight (P = .006), percentage of fat mass (P = .017), kg of fat mass (P = .006), and body mass index (P = .004). Physical activity and total daily protein intake were the strongest predictors of the amount of lean body mass (P = .01 and .003, respectively).
Conclusion
The association between somatic protein and visceral protein stores is weak in patients with CHD. Whereas increased levels of physical activity and total daily protein intake are associated with higher lean body mass in patients with CHD, higher adiposity is associated with higher C-reactive protein and lower albumin values.
To access this article, please choose from the options below
This work is supported in part by National Institutes of Health Grants R01 DK-45604, K24 DK-062849 and Diabetes Research and Training Center Grant DK-20593 from the National Institute of Diabetes, Digestive and Kidney Diseases, and General Clinical Research Center Grant No. M01 RR-00095 from the National Center for Research Resources and Satellite Health Extramural Grant Program. L. B. Pupim is currently an employee of Amgen, Inc. (since August of 2005) and declares no conflict of interest with the work presented.
PII: S1051-2276(07)00002-7
doi:10.1053/j.jrn.2007.01.003
© 2007 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.

